Tourmaline Bio (TRML) News Today $23.06 +0.60 (+2.67%) Closing price 04:00 PM EasternExtended Trading$22.54 -0.51 (-2.23%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRML Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Analysts Set Expectations for Tourmaline Bio FY2025 EarningsAugust 19 at 2:29 AM | marketbeat.comFY2025 EPS Estimates for Tourmaline Bio Lowered by AnalystAugust 19 at 2:17 AM | americanbankingnews.comTourmaline Bio Q3 EPS Forecast Raised by Leerink PartnrsAugust 19 at 2:39 AM | marketbeat.comLifesci Capital Expects Higher Earnings for Tourmaline BioAugust 19 at 2:39 AM | marketbeat.comWhat is Wedbush's Forecast for Tourmaline Bio Q3 Earnings?August 19 at 2:39 AM | marketbeat.comLeerink Partnrs Expects Higher Earnings for Tourmaline BioAugust 19 at 2:16 AM | americanbankingnews.comTourmaline Bio Q3 EPS Estimate Raised by Lifesci CapitalAugust 19 at 2:16 AM | americanbankingnews.comWedbush Estimates Tourmaline Bio's Q3 Earnings (NASDAQ:TRML)August 18 at 2:43 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPSAugust 17, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Receives "Buy" Rating from Chardan CapitalAugust 16, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Receives Buy Rating from GuggenheimAugust 16, 2025 | marketbeat.comBrokerages Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $49.33August 16, 2025 | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Receives Buy Rating from Chardan CapitalAugust 15, 2025 | americanbankingnews.comTourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of "Buy" by BrokeragesAugust 14, 2025 | marketbeat.comTourmaline Bio, Inc.: Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 13, 2025 | finanznachrichten.deTourmaline Bio reports Q2 EPS (90c), consensus (93c)August 13, 2025 | msn.comTourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 13, 2025 | globenewswire.comTourmaline Bio (TRML) Expected to Announce Earnings on ThursdayAugust 7, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Position Boosted by Federated Hermes Inc.August 6, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Trading Down 4.6% - Time to Sell?August 5, 2025 | marketbeat.comBMO Capital Remains a Buy on Tourmaline Bio (TRML)July 30, 2025 | theglobeandmail.comTourmaline Bio (NASDAQ:TRML) Trading 7% Higher - Time to Buy?July 26, 2025 | marketbeat.comJennison Associates LLC Cuts Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML)July 22, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from BrokeragesJuly 19, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Shares Down 2.1% - Should You Sell?July 16, 2025 | marketbeat.comTourmaline Bio Inc News (TRML) - Investing.comJuly 3, 2025 | investing.comTRML - Tourmaline Bio Inc Dividends - MorningstarJune 26, 2025 | morningstar.comMTRML - Tourmaline Bio Inc Executives - MorningstarJune 24, 2025 | morningstar.comMTourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from BrokeragesJune 24, 2025 | marketbeat.comCantor Fitzgerald Weighs in on Tourmaline Bio FY2026 EarningsJune 11, 2025 | marketbeat.comTwo Sigma Investments LP Sells 21,904 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)June 10, 2025 | marketbeat.comTourmaline Bio Elects Directors and Ratifies AuditorJune 6, 2025 | tipranks.comTourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by Bank of America Corp DEJune 6, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Trading Up 7.2% - Here's What HappenedJune 5, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of "Buy" from BrokeragesMay 31, 2025 | marketbeat.comH.C. Wainwright maintains $50 target on Tourmaline Bio stockMay 29, 2025 | uk.investing.comH.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 ResultsMay 29, 2025 | msn.comMillennium Management LLC Has $7.40 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML)May 28, 2025 | marketbeat.comLeerink Partnrs Comments on Tourmaline Bio FY2026 EarningsMay 27, 2025 | marketbeat.com29,844 Shares in Tourmaline Bio, Inc. (NASDAQ:TRML) Purchased by Rafferty Asset Management LLCMay 25, 2025 | marketbeat.comBMO Sees Overreaction, Maintains Rating and Price Target on Tourmaline Bio (TRML)May 23, 2025 | msn.comWexford Capital LP Purchases New Position in Tourmaline Bio, Inc. (NASDAQ:TRML)May 22, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Stake Increased by Velan Capital Investment Management LPMay 21, 2025 | marketbeat.comTourmaline Bio posts mid-stage data for anti-inflammatory agentMay 20, 2025 | msn.comTourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 InhibitionMay 20, 2025 | seekingalpha.comTourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025May 19, 2025 | globenewswire.comLeerink Partnrs Comments on Tourmaline Bio FY2025 EarningsMay 10, 2025 | marketbeat.comBrokers Set Expectations for Tourmaline Bio FY2025 EarningsMay 9, 2025 | marketbeat.comQ2 EPS Estimates for Tourmaline Bio Decreased by AnalystMay 9, 2025 | marketbeat.comLeerink Partnrs Weighs in on Tourmaline Bio Q2 EarningsMay 9, 2025 | marketbeat.com Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Email Address TRML Media Mentions By Week TRML Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRML News Sentiment▼0.430.52▲Average Medical News Sentiment TRML News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRML Articles This Week▼263▲TRML Articles Average Week Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bausch Health Cos News Ocular Therapeutix News Agios Pharmaceuticals News Denali Therapeutics News IDEAYA Biosciences News Tarsus Pharmaceuticals News Disc Medicine News Harmony Biosciences News Mesoblast News CG Oncology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRML) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access